| The Foot And Ankle Group Pc | |
|
1515 Laney Walker Blvd, Augusta, GA 30904-5827 | |
| (706) 724-0586 | |
| (706) 724-4468 |
| Full Name | The Foot And Ankle Group Pc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Primary Podiatric Medicine |
| Location | 1515 Laney Walker Blvd, Augusta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720139710 | NPI | - | NPPES |
| 300032875A | Medicaid | GA |
| Provider Name | Mary Louise Ottinger |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1821149782 PECOS PAC ID: 0244356681 Enrollment ID: I20100923000335 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For middle-aged men, eating higher amounts of protein was associated with a slightly elevated risk for heart failure than those who ate less protein, according to new research in Circulation: Heart Failure, an American Heart Association journal.
The chemical attacks in Syria could lower the bar for use of chemical weapons by terrorist organizations or rogue nations that could eventually pose a threat to the United States, says Alexander Garza, M.D., former assistant secretary of health affairs and chief medical officer at the U.S. Department of Homeland Security.
InflaRx announced today the successful completion of its recent clinical phase I study investigating its lead drug candidate IFX-1, a new first in class monoclonal antibody inhibiting complement driven inflammation. The trial reached its anticipated endpoints, demonstrating that IFX-1 is safe and well tolerated while displaying desirable PK and PD parameters.
› Verified 2 days ago
| Provider Name | Kent Edward Kronowski |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1881745842 PECOS PAC ID: 1254454945 Enrollment ID: I20101007000249 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For middle-aged men, eating higher amounts of protein was associated with a slightly elevated risk for heart failure than those who ate less protein, according to new research in Circulation: Heart Failure, an American Heart Association journal.
The chemical attacks in Syria could lower the bar for use of chemical weapons by terrorist organizations or rogue nations that could eventually pose a threat to the United States, says Alexander Garza, M.D., former assistant secretary of health affairs and chief medical officer at the U.S. Department of Homeland Security.
InflaRx announced today the successful completion of its recent clinical phase I study investigating its lead drug candidate IFX-1, a new first in class monoclonal antibody inhibiting complement driven inflammation. The trial reached its anticipated endpoints, demonstrating that IFX-1 is safe and well tolerated while displaying desirable PK and PD parameters.
› Verified 2 days ago
| Provider Name | Kirmanj T Atrushi |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1871026179 PECOS PAC ID: 7911329354 Enrollment ID: I20200612000582 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For middle-aged men, eating higher amounts of protein was associated with a slightly elevated risk for heart failure than those who ate less protein, according to new research in Circulation: Heart Failure, an American Heart Association journal.
The chemical attacks in Syria could lower the bar for use of chemical weapons by terrorist organizations or rogue nations that could eventually pose a threat to the United States, says Alexander Garza, M.D., former assistant secretary of health affairs and chief medical officer at the U.S. Department of Homeland Security.
InflaRx announced today the successful completion of its recent clinical phase I study investigating its lead drug candidate IFX-1, a new first in class monoclonal antibody inhibiting complement driven inflammation. The trial reached its anticipated endpoints, demonstrating that IFX-1 is safe and well tolerated while displaying desirable PK and PD parameters.
› Verified 2 days ago
| Provider Name | Mohammed Qureshi |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1578057642 PECOS PAC ID: 4688921828 Enrollment ID: I20210713002005 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For middle-aged men, eating higher amounts of protein was associated with a slightly elevated risk for heart failure than those who ate less protein, according to new research in Circulation: Heart Failure, an American Heart Association journal.
The chemical attacks in Syria could lower the bar for use of chemical weapons by terrorist organizations or rogue nations that could eventually pose a threat to the United States, says Alexander Garza, M.D., former assistant secretary of health affairs and chief medical officer at the U.S. Department of Homeland Security.
InflaRx announced today the successful completion of its recent clinical phase I study investigating its lead drug candidate IFX-1, a new first in class monoclonal antibody inhibiting complement driven inflammation. The trial reached its anticipated endpoints, demonstrating that IFX-1 is safe and well tolerated while displaying desirable PK and PD parameters.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| The Foot And Ankle Group Pc 1515 Laney Walker Blvd, Augusta, GA 30904-5827 Ph: (706) 724-0586 | The Foot And Ankle Group Pc 1515 Laney Walker Blvd, Augusta, GA 30904-5827 Ph: (706) 724-0586 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For middle-aged men, eating higher amounts of protein was associated with a slightly elevated risk for heart failure than those who ate less protein, according to new research in Circulation: Heart Failure, an American Heart Association journal.
The chemical attacks in Syria could lower the bar for use of chemical weapons by terrorist organizations or rogue nations that could eventually pose a threat to the United States, says Alexander Garza, M.D., former assistant secretary of health affairs and chief medical officer at the U.S. Department of Homeland Security.
InflaRx announced today the successful completion of its recent clinical phase I study investigating its lead drug candidate IFX-1, a new first in class monoclonal antibody inhibiting complement driven inflammation. The trial reached its anticipated endpoints, demonstrating that IFX-1 is safe and well tolerated while displaying desirable PK and PD parameters.
› Verified 2 days ago
Henry Greene Bryant Iii, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 2030 Walton Way, Augusta, GA 30904 Phone: 706-738-1925 Fax: 706-738-0705 | |
Dr. James Austin Denmark, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2260 Wrightsboro Rd, Suite 154, Augusta, GA 30904 Phone: 706-364-0263 | |
Mickey Dwight Stapp, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1416 Wainbrook Dr, Augusta, GA 30909 Phone: 706-312-3668 Fax: 706-312-3670 | |
Augusta Center For Foot And Ankle Surgery Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1515 Laney Walker Blvd, Augusta, GA 30904 Phone: 706-724-9224 Fax: 706-724-4468 | |
Fyne Foot Care Center Podiatrist Medicare: Medicare Enrolled Practice Location: 1710 Central Ave, Augusta, GA 30904 Phone: 706-373-4402 | |
Christopher David Anna, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1416 Wainbrook Dr, Augusta, GA 30909 Phone: 706-312-3668 Fax: 706-312-3670 | |
Upperline Healthcare, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1416 Wainbrook Drive, Augusta, GA 30909 Phone: 706-312-3668 |